Benzodiazepine self-administration in humans and laboratory animals - implications for problems of long-term use and abuse
The DOI matches its Crossref record; 205 of the 205 references it cites were found in a registry or an index.
Abstract
Drug reinforcement may represent the primary behavioral-pharmacological mechanism underlying two types of problematic use of benzodiazepines--recreational abuse by polydrug abusers and inappropriate chronic use by patients. High dose polydrug abuse for the purpose of getting high is readily recognized as a significant social problem. Inappropriate chronic benzodiazepine use is more subtle but relatively common: for anxiolytics, 36% of past-year users (3% of the adult population in the US) report using these drugs for 4 consecutive months or longer. The risks of such long-term use are much better documented than the benefits. This paper provides a current review of various problems that have been identified with the long-term use and the recreational abuse of benzodiazepines, including memory impairment, risk of accidents, falls and hip fractures in the elderly, a withdrawal syndrome, brain damage, overuse in the elderly, overuse by chronic pain patients, overuse by alcoholics and recreational abuse among alcoholics and polydrug abusers. A comprehensive review of the literature on benzodiazepine reinforcing effects in humans and laboratory animals is also provided. Drug self-administration studies in humans and laboratory animals provide models of both types of problematic benzodiazepine use. Recreational abuse of benzodiazepines has been modeled in human research with polydrug abusers and in laboratory animal studies, which show that the reinforcing effect of benzodiazepines is intermediate relative to other sedative compounds and is increased in subjects with histories of previous sedative drug self-administration. The problem of inappropriate long-term use of benzodiazepines by people without histories of drug abuse has been partially modeled in human studies showing that benzodiazepines function as reinforcers in subjects with anxiety, insomnia, and histories of moderate alcohol consumption, and in preclinical studies showing stable, low-rate benzodiazepine self-injection with concurrent physical dependence under conditions of continuous availability. Both human and animal research suggests that the drug history and current behavioral context may be important in the establishment of benzodiazepines as reinforcers. Limited human and animal research provides little support for the common belief that physical dependence enhances benzodiazepine reinforcement.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although most patients taking BZDs as prescribed will not develop BZD use disorder, the risk of physical dependence and BZD use disorder increases with time, particularly in patients who use alcohol or other substances.31”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [31]
In the citing paper
“Thus, it is important to note that, even though zolpidem does not seem to engender any obvious tolerance development, zolpidem can lead to withdrawal symptoms that are comparable to those seen after chronic classical benzodiazepine treatment [29, 77].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [77]
Citations
Cites
Risk Factors for Hip Fracture in White Women
Cummings, S. R., Nevitt, M. C., Browner, W. S., Stone, K., Fox, K. M., Ensrud, K. E., Cauley, J., Black, D., & Vogt, T. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321202 · Cited by 3,595
Psychotropic Drug Use and the Risk of Hip Fracture
Ray, W. A., Griffin, M. R., Schaffner, W., Baugh, D. K., & Melton, L. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702123160702 · Cited by 1,000
American drinking practices : a national study of drinking behavior and attitudes
Cahalan, D., Cisin, I. H., & Crossley, H. M. (1969) · Medical Entomology and Zoology · Cited by 637
Benzodiazepines: use, abuse, and consequences.
Woods, J. H., Katz, J. L., & Winger, G. (1992) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00468-5 · Cited by 560
Benzodiazepines of Long and Short Elimination Half-life and the Risk of Hip Fracture
Ray, W. A. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03430230088031 · Cited by 548
Psychoactive Drugs and the Risk of Injurious Motor Vehicle Crashes in Elderly Drivers
Ray, W. A., Fought, R. L., & Decker, M. D. (1992) · American Journal of Epidemiology · doi:10.1093/aje/136.7.873 · Cited by 417
Benzodiazepines, memory and mood: a review
Valerie Curran, H. (1991) · Psychopharmacology · doi:10.1007/bf02316856 · Cited by 401
Withdrawal Reaction after Long-Term Therapeutic Use of Benzodiazepines
Busto, U., Sellers, E. M., Naranjo, C. A., Cappell, H., Sanchez-Craig, M., & Sykora, K. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610023151403 · Cited by 369
Long-term Therapeutic Use of Benzodiazepines: I. Effects of Abrupt Discontinuation
Rickels, K. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810220015002 · Cited by 332
Goa, K. L., & Ward, A. (1986) · Drugs · doi:10.2165/00003495-198632020-00002 · Cited by 332
Cited by
Items 101–200 of 262
Analytical Methodology for the Detection of Benzodiazepine Consumption in Opioid-Dependent Subjects
Segura, M., Barbosa, J., Torrens, M., Farré, M., Castillo, C., Segura, J., & de la Torre, R. (2001) · Journal of Analytical Toxicology · doi:10.1093/jat/25.2.130 · Cited by 23
Predictors of benzodiazepine discontinuation in subjects manifesting complicated dependence
VORMA, H., NAUKKARINEN, H. H., SARNA, S. J., & KUOPPASALMI, K. I. (2005) · Substance Use & Misuse · doi:10.1081/ja-200052433 · Cited by 22
“Benzodiazepine use among alcoholic subjects is higher than it is in the general population (Griffiths and Weerts, 1997).”
BackgroundBDZs, Designer BDZs and Z-drugs: Pharmacology and Misuse Insights
Zaami, S., Graziano, S., Tittarelli, R., Beck, R., & Marinelli, E. (2021) · Current Pharmaceutical Design · doi:10.2174/1381612827666210917145636 · Cited by 27
Muzaale, A. D., Daubresse, M., Bae, S., Chu, N. M., Lentine, K. L., Segev, D. L., & McAdams‐DeMarco, M. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.13341019 · Cited by 24
Manor, R., Kumarnsit, E., Samerphob, N., Rujiralai, T., Puangpairote, T., & Cheaha, D. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114193 · Cited by 23
Parra, A., Everss, E., Monleón, S., Vinader‐Caerols, C., & Arenas, M. C. (2002) · Neuroscience Research Communications · doi:10.1002/nrc.10046 · Cited by 22
Chronic benzodiazepine administration facilitates the subsequent development of ethanol dependence
Martijena, I. D., Lacerra, C., Bustos, S. G., & Molina, V. A. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03218-2 · Cited by 28
Flumazenil-precipitated withdrawal in healthy volunteers following repeated diazepam exposure
Mintzer, M. Z., & Griffiths, R. R. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2009-1 · Cited by 23
Self-citationGuina, J., Nahhas, R. W., Goldberg, A., & Farnsworth, S. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5080070 · Cited by 21
Chronic cocaine differentially affects diazepam’s anxiolytic and anticonvulsant actions
Lilly, S. M., & Tietz, E. I. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02858-4 · Cited by 22
Skurtveit, S. O., Furu, K., Bramness, J. G., & Tverdal, A. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1616 · Cited by 21
Is quetiapine a drug of abuse? Reexamining the issue of addiction
Tcheremissine, O. V. (2008) · Expert Opinion on Drug Safety · doi:10.1517/14740330802496883 · Cited by 19
Ostroumov, A., Wittenberg, R. E., Kimmey, B. A., Taormina, M. B., Holden, W. M., McHugh, A. T., & Dani, J. A. (2020) · eNeuro · doi:10.1523/eneuro.0348-19.2020 · Cited by 24
Fischer, B. D., Teixeira, L. P., Linn, M. L. V., Namjoshi, O. A., Cook, J. M., & Rowlett, J. K. (2013) · Psychopharmacology · doi:10.1007/s00213-013-2975-2 · Cited by 20
A role for AMPA/kainate receptors in conditioned place preference induced by diazepam in the rat
Gray, A. M., Allison, C., & Pratt, J. A. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00371-7 · Cited by 19
An 87-year-old woman taking a benzodiazepine
Salzman, C. (1999) · JAMA · doi:10.1001/jama.281.12.1121 · Cited by 18
Caffeinated Alcoholic Beverages – An Emerging Trend in Alcohol Abuse
Hauser, S. R. (2013) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s4-012 · Cited by 20
Medication and Substance Abuse
Roehrs, T., & Roth, T. G. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6645-3.00132-8 · Cited by 19
Nattala, P., Leung, K. S., Abdallah, A. B., & Cottler, L. B. (2010) · Addictive Behaviors · doi:10.1016/j.addbeh.2010.09.002 · Cited by 18
McMahon, L. R., & France, C. P. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706550 · Cited by 20
Shen, G., Mohamed, M. S., Das, P., & Tietz, E. I. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371394 · Cited by 18
Schwienteck, K. L., Li, G., Poe, M. M., Cook, J. M., Banks, M. L., & Negus, S. S. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4615-8 · Cited by 19
Intravenous self-administration of gamma-hydroxybutyrate (GHB) in baboons
Goodwin, A. K., Kaminski, B. J., Griffiths, R. R., Ator, N. A., & Weerts, E. M. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.10.006 · Cited by 18
Self-citationA therapeutic dose of zolpidem has limited abuse-like effects in drug-naïve females: A pilot study
Licata, S. C., Penetar, D. M., Dunlap, S., & Lukas, S. E. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.09.011 · Cited by 16
de la Peña, J. B., & Cheong, J. H. (2016) · Drug Testing and Analysis · doi:10.1002/dta.1987 · Cited by 18
Morales, M., Varlinskaya, E. I., & SPEAR, L. P. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.05.004 · Cited by 18
Sedative-Hypnotics Are Widely Abused by Drivers Apprehended for Driving Under the Influence of Drugs
Kriikku, P., Hurme, H., Wilhelm, L., Rintatalo, J., Hurme, J., Kramer, J., & Ojanperä, I. A. (2014) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000138 · Cited by 15
Kovačević, J., Stamenić, T. T., Tiruveedhula, V. V. N. P. B., Batinić, B., Namjoshi, O. A., Milić, M., Joksimovic, S. M., Cook, J. M., & Savić, M. M. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2014.03.002 · Cited by 17
Duke, A. N., Tiruveedhula, V. V. N. P. B., Sharmin, D., Knutson, D. E., Cook, J. M., Platt, D. M., & Rowlett, J. K. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108985 · Cited by 15
Self-injection of flunitrazepam alone and in the context of methadone maintenance in baboons
Ator, N. A., Griffiths, R. R., & Weerts, E. M. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.09.007 · Cited by 15
Self-citationHigh rates of midazolam self-administration in squirrel monkeys
Munzar, P., Yaşar, S., Redhi, G. H., Justinová, Z., & Goldberg, S. R. (2001) · Behavioural Pharmacology · doi:10.1097/00008877-200107000-00004 · Cited by 14
The potential utility of some legal highs in CNS disorders
Davidson, C., & Schifano, F. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.07.010 · Cited by 18
Weed, P. F., France, C. P., & Gerak, L. R. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.240200 · Cited by 13
The basic pharmacoepidemiology of benzodiazepine use in Norway 2004-9
Bramness, J. G., & Sexton, J. A. (2011) · Norsk Epidemiologi · doi:10.5324/nje.v21i1.1423 · Cited by 14
Abuse potential assessment of the dual orexin receptor antagonist daridorexant in rats
Steiner, M. A., Toeroek-Schafroth, M., Giusepponi, M. E., Dacome, L., & Tessari, M. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231215415 · Cited by 12
Spence, A. L., Guerin, G. F., & Goeders, N. E. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.041 · Cited by 12
Kurhe, Y., Radhakrishnan, M., Devadoss, T., & Gupta, D. (2014) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.125186 · Cited by 15
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.013 · Cited by 12
Debate: Are Benzodiazepines Appropriate Treatments for Patients with Substance Use Disorders? Yes
Park, T. W. (2017) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000292 · Cited by 13
de la Peña, J. B., Peña, I. J. D., Lee, H. L., Peña, I. D., Shin, C. Y., Sohn, A. R., & Cheong, J. H. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.07.016 · Cited by 11
Sexual Orientation and College Students’ Reasons for Nonmedical Use of Prescription Drugs
Backus, F. R., McDaniel, A. E., & Shadick, R. N. (2017) · Substance Use & Misuse · doi:10.1080/10826084.2016.1268631 · Cited by 14
Gerak, L. R., Weed, P. F., Maguire, D. R., & France, C. P. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.04.024 · Cited by 11
Sedative-Hypnotics and Anxiolytics
Arnaout, B., & Petrakis, I. L. (2010) · Springer eBooks · doi:10.1007/978-1-4419-0338-9_23 · Cited by 10
The Combination of Metyrapone and Oxazepam for the Treatment of Cocaine and Other Drug Addictions
Goeders, N. E., Guerin, G. F., & Schmoutz, C. D. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-420118-7.00011-1 · Cited by 10
The Use of Benzodiazepines among Kratom ( Mitragyna Speciosa Korth.) Users
Singh, D., Narayanan, S., Grundmann, O., Boyer, E. W., & Vicknasingam, B. K. (2019) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2019.1632505 · Cited by 9
Lopes, L. T., Canto‐de‐Souza, L., Baptista‐de‐Souza, D., de Souza, R. R., Nunes‐de‐Souza, R. L., & Canto‐de‐Souza, A. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113588 · Cited by 9
Cardona-Acosta, A. M., Sial, O. K., Parise, L. F., Gnecco, T., Marti, G. E., & Bolaños‐Guzmán, C. A. (2023) · Scientific Reports · doi:10.1038/s41598-023-37696-8 · Cited by 9
Recent findings and advancements in the detection of designer benzodiazepines: a brief review
Wu, D., & Fu, L. (2023) · Archives of Industrial Hygiene and Toxicology · doi:10.2478/aiht-2023-74-3771 · Cited by 9
Fischer, B. D., Platt, D. M., Rallapalli, S., Namjoshi, O. A., Cook, J. M., & Rowlett, J. K. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.10.026 · Cited by 10
A 5-year follow-up study of users of benzodiazepine: starting with diazepam versus oxazepam
Tvete, I. F., Bjørner, T., & Skomedal, T. (2016) · British Journal of General Practice · doi:10.3399/bjgp16x684385 · Cited by 9
Duke, A. N., Platt, D. M., & Rowlett, J. K. (2020) · Psychopharmacology · doi:10.1007/s00213-019-05447-1 · Cited by 10
Yaşar, S. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01533-4 · Cited by 9
Targeting the treatment of drug abuse with molecular imaging
Schiffer, W. K., Liebling, C. N. B., Patel, V. D., & Dewey, S. L. (2007) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2007.05.004 · Cited by 9
Nonmedical abuse of benzodiazepines in opiate-dependent patients in tehran, iran.
Babakhanian, M., Sadeghi, M., Mansoori, N., Mehrjerdi, Z. A., & Tabatabai, M. (2012) · PubMed Central · Cited by 12
Matsumoto, T., Ozaki, S., Kobayashi, O., & Wada, K. (2015) · Activitas Nervosa Superior · doi:10.1007/bf03379620 · Cited by 9
Goodwin, A. K., Kaminski, B. J., & Weerts, E. M. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2851-5 · Cited by 8
Self-citationSubstance Use Disorders: A Biopsychosocial Perspective
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515 · Cited by 11
Effects of oxycodone and diazepam alone and in combination on operant nociception
Leonard, M. Z., & Kangas, B. D. (2020) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000542 · Cited by 8
Yanofski, J. (2011) · PubMed · Cited by 14
Benzodiazepine Usage in the North Eastern Health Board Region of the Republic of Ireland
Henman, M. C., Vivero, L. E., Gustafsson, A., & Mulvenna, K. (2004) · Arrow@dit (Dublin Institute of Technology) · Cited by 9
A drug identification system for intoxicated drivers based on a systematic review
González‐Briones, A., Ramos, J., & Paz, J. F. D. (2016) · ADCAIJ ADVANCES IN DISTRIBUTED COMPUTING AND ARTIFICIAL INTELLIGENCE JOURNAL · doi:10.14201/adcaij20154483101 · Cited by 7
Reintroduction of quazepam: an update on comparative hypnotic and adverse effects
Moniri, N. H. (2019) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000277 · Cited by 7
Chen, T.-T., Ko, C., Chen, S., Yen, C., Su, P.-W., Hwang, T., Lin, J., & Yen, C. (2014) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2014.04.004 · Cited by 8
Benzodiazepiner til personer med rusmiddelproblemer?
Waal, H., & Bramness, J. G. (2010) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.09.0687 · Cited by 6
Gunter, B. W., Platt, D. M., & Rowlett, J. K. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.08.003 · Cited by 6
Medication and Substance Abuse
Roehrs, T., & Roth, T. G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-24288-2.00140-9 · Cited by 9
Martijena, I. D., Bustos, S. G., Bertotto, M. E., & Molina, V. A. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.05.009 · Cited by 9
Rush, C. R., & Ali, J. A. (1999) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.7.3.257 · Cited by 6
Development of self-efficacy and expectancy measures for benzodiazepines
Parr, J. M., Kavanagh, D. J., Young, R. M., & Connor, J. P. (2009) · Addictive Behaviors · doi:10.1016/j.addbeh.2009.04.014 · Cited by 6
Effect of relaxation therapy on benzodiazepine use in patients with medically unexplained symptoms
Hashimoto, K., Takeuchi, T., Koyama, A., Hiiragi, M., Suka, S., & Hashizume, M. (2020) · BioPsychoSocial Medicine · doi:10.1186/s13030-020-00187-7 · Cited by 5
Dooley, T. P., Benjamin, A. B., & Thomas, T. (2019) · doi:10.36648/2471-9854.5.2.63 · Cited by 5
Relative reinforcing effects of different benzodiazepine doses for rhesus monkeys
Gomez, T. H., Roache, J. D., & Meisch, R. A. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00222-3 · Cited by 5
Oittinen, H., Rameis, H., Saria, A., & Zernig, G. (2001) · Pharmacology · doi:10.1159/000056083 · Cited by 5
Modern epidemiology of anxiety: results of the Zurich cohort study
Angst, J. (1999) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/(sici)1099-1077(199908)14:1+<s29::aid-hup115>3.0.co;2-7 · Cited by 14
McMahon, L. R., & France, C. P. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0028-1 · Cited by 5
Roehrs, T., & Roth, T. G. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3375-0_30 · Cited by 4
Pharmacotherapy of benzodiazepines in the aged patient
Bourin, M., & Renard, C. (2001) · Psychiatry and Clinical Psychopharmacology · Cited by 4
Long-Term Benzodiazepine Use in Patients With Major Depressive Disorder in China
Li, Y.-H., Xiang, Y., Su, Y., Shu, L., Yu, X., Kilbourne, A. M., Ungvari, G. S., Chiu, H. F. K., Ma, C., Wang, G.-H., et al. (2013) · Perspectives In Psychiatric Care · doi:10.1111/ppc.12035 · Cited by 4
Drugs Inducing Insomnia as an Adverse Effect
Malangu, N. (2012) · InTech eBooks · doi:10.5772/30921 · Cited by 9
Unødvendige nyord om avhengighet
Bramness, J. G., Waal, H., & Mørland, J. G. (2009) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.09.0297 · Cited by 4
Managing Dependence and Withdrawal With Newer Hypnotic Medications in the Treatment of Insomnia.
LADER, M. H. (2013) · The Primary Care Companion to The Journal of Clinical Psychiatry · Cited by 4
Buysse, D. J., Germain, A., Moul, D. E., & Nofzinger, E. A. (2005) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.3.4.568 · Cited by 7
Prescription Drug Abuse: Risks and Prevention
Bramness, J. G. (2014) · Springer eBooks · doi:10.1007/978-88-470-5322-9_29 · Cited by 4
Abhängigkeitspotenzial der GABA-A-Rezeptor-agonistischen Nicht-Benzodiazepin-Hypnotika
Lange, K., Wodarz, N., & Hajak, G. (2007) · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice · doi:10.1024/2007.04.02 · Cited by 4
Mother's little helper turned a foe: Alprazolam use, misuse, and abuse
Cardona-Acosta, A. M., Meisser, N., Vardeleon, N. I., Steiner, H., & Bolaños‐Guzmán, C. A. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111137 · Cited by 5
Using a rich-lean transition procedure to evaluate putative antianxiety medications
Toegel, F., Toegel, C., Rowlett, J. K., Woods, J. A., Zamarripa, C. A., Doyle, W. S., Freeman, K. B., & Huskinson, S. L. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103657 · Cited by 3
Hwang, S.-B., Lee, J.-G., Lee, Y., Kook, W.-A., Kim, S., Donio, A. L., Min, H.-W., Kim, Y., Lee, S., & Jang, C. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00346 · Cited by 3
Rowlett, J. K. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00142-3 · Cited by 3
Kayser, R. R., Haney, M., & Simpson, H. B. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.626150 · Cited by 3
Management of chronic insomnia using hypnotics: a friend or a foe?
Basu, A., Joshi, T., Pal, A., & Gupta, R. M. (2022) · Sleep and Biological Rhythms · doi:10.1007/s41105-021-00363-4 · Cited by 4
Stanos, S. P., Tyburski, M. D., & Harden, R. N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-62539-5.00037-0 · Cited by 3
A pilot study of benzodiazepine cue-induced craving
McHugh, R. K., Korte, F. M., McCarthy, M. D., & Geyer, R. B. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109443 · Cited by 3
Kelly, T. H. (2002) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.10.2.92 · Cited by 3
Drug dependency: benzodiazepines
Ashton, H. (2001) · Cambridge University Press eBooks · doi:10.1017/cbo9780511543579.161 · Cited by 3
Babalonis, S. L., Lile, J. A., Martin, C. A., & Kelly, T. H. (2011) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328349fc02 · Cited by 2
de la Villarmois, E. A., & Pérez, M. F. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14515 · Cited by 2
Clinical applications of small-molecule GABAAR modulators for neurological disorders
Chen, G., Xu, M., Chen, Z., & Yang, F. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107983 · Cited by 4
Chronic high‐dose nitrazepam dependence 123I‐IMP SPECT and EEG studies
Kitabayashi, Y., Ueda, H., Narumoto, J., Iizumi, H., Tsuchida, H., Murata, N., Nakajima, S., & Fukui, K. (2001) · Addiction Biology · doi:10.1080/13556210120056507 · Cited by 2
A survey of community drug team prescribing policies and client views
Luty, J. S., OʼGara, C., Sessay, M., & Sarkhel, A. (2009) · Journal of Substance Use · doi:10.3109/14659890902967073 · Cited by 2
Substitute addictions and transplantation
Coffman, K. L. (1999) · Current Opinion in Organ Transplantation · doi:10.1097/00075200-199906000-00010 · Cited by 2
Metadata
- Authors
- Griffiths, R. R., & Weerts, E. M.
- Affiliations
- Johns Hopkins University (US)
- Venue
- Psychopharmacology
- Published
- 1997-11-03
- Volume
- 134
- Issue
- 1
- Pages
- 1-37
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2038299708
- Cited by
- 260
- References
- 205
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 3 · 2023: 6 · 2022: 2 · 2021: 6 · 2020: 27 · 2019: 7 · 2018: 5 · 2017: 7 · 2016: 13 · 2015: 7 · 2014: 12 · 2013: 9 · 2012: 16
- FWCI
- 5.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- DigitalGeorgetown (Georgetown University Library) (submittedVersion)
- Funders
- National Institutes of Health (5r01da001147-28)
- National Institute on Drug Abuse (R01DA003889, R01 DA01147, R01DA03889)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- benzodiazepines, self-administration, drug reinforcement, recreational drug abuse, polydrug abuse, memory impairment, benzodiazepine withdrawal syndrome, physical dependence, chronic pain patients, alcoholics, sedatives, anxiolytics, insomnia
- MeSH terms
- Animals, Benzodiazepines, Humans, Self Administration, Anti-Anxiety Agents, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.